1. Home
  2. PRTH vs DAWN Comparison

PRTH vs DAWN Comparison

Compare PRTH & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Priority Technology Holdings Inc.

PRTH

Priority Technology Holdings Inc.

HOLD

Current Price

$4.96

Market Cap

451.1M

Sector

Technology

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$21.31

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRTH
DAWN
Founded
2005
2018
Country
United States
United States
Employees
1019
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
451.1M
2.2B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PRTH
DAWN
Price
$4.96
$21.31
Analyst Decision
Buy
Buy
Analyst Count
3
10
Target Price
$8.33
$26.00
AVG Volume (30 Days)
279.5K
5.7M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$158,182,000.00
Revenue This Year
$10.18
$53.52
Revenue Next Year
$9.33
$27.10
P/E Ratio
$10.38
N/A
Revenue Growth
N/A
20.60
52 Week Low
$4.44
$5.64
52 Week High
$8.89
$21.40

Technical Indicators

Market Signals
Indicator
PRTH
DAWN
Relative Strength Index (RSI) 31.06 82.10
Support Level $4.44 $6.45
Resistance Level $6.01 N/A
Average True Range (ATR) 0.23 0.55
MACD -0.06 1.02
Stochastic Oscillator 7.65 99.21

Price Performance

Historical Comparison
PRTH
DAWN

About PRTH Priority Technology Holdings Inc.

Priority Technology Holdings Inc is a provider of merchant acquiring and commercial payment solutions to small and medium business enterprises in the United States. The company has three reportable segments which are SMB Payments, B2B Payments, and Enterprise Payments. SMB Payments segment which generates the majority of revenue provides full-service acquiring and payment-enabled solutions for B2C transactions, leveraging Priority's proprietary software platform, distributed through ISO; the B2B Payments segment provides AP automation solutions to corporations, software partners, & industry FIs: and Enterprise Payments segment provides embedded payment & treasury solutions to enterprise customers to modernize legacy platforms & accelerate software partners' strategies to monetize payments.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.

Share on Social Networks: